Website Logo

Press

Keep up-to-date with relevant news, important announcements and key market insights.

READ MORE
FEATURED

Together Caring for Rare Disease

By loading the video, you agree to YouTube’s privacy policy.Learn more Load video Always unblock YouTube

Resource

About Bionical Emas

Bionical Emas is the only Contract Research Organization that combines Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP) to deliver a unique, seamless approach to bring life-changing medicines to patients around the world.

READ MORE

Webinar: A Patient Panel, discussing Access Challenges with their unique patient perspectives

Resource

READ MORE

Webinar: Metabolic Support UK Annual Conference

Resource

READ MORE

G1 Therapeutics, Inc and Bionical Emas Launch Expanded Access Program in the United States

Press Release

READ MORE

Fact Sheet: Nuances in Pharmacovigilance case processing in Early Access Programs

Resource

READ MORE

Fact Sheet: Four things to think about: PVG in EAPs

Resource

READ MORE

Fact Sheet: Pharmacovigilance & CIOMS

Resource

READ MORE

Webinar: What does Early Access actually mean?

Resource

READ MORE

Let’s Face This Together: Bionical Emas supports rare disease charity, Same But Different

News

READ MORE

Bionical Emas and Jazz Pharmaceuticals Enter into an Agreement for Expanded Access to Lurbinectedin in Relapsed Small Cell Lung Cancer in the United States

Press Release

READ MORE

Women In Healthcare – PharmaTimes May 2020

News

READ MORE

The Early Access Voyage – Rare Revolution Spring 2020

News

READ MORE

A Statement From The Bionical Emas Group On Guidance & Measures Regarding COVID-19

News

3 / 4